ArticleScientific reports2017

A study on the risk of fungal infection with tofacitinib (CP-690550), a novel oral agent for rheumatoid arthritis.

Yong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.